Tata Chemicals Ltd (TATACHEM) — Financial Results | 26 September 2026

Investor Takeaways

• Revenue reached ₹4,255 Cr in Q1FY27, up from ₹3,877 Cr in Q2FY26, with profit turning positive at ₹154 Cr and OPM at 6.5%.
• Q4FY26 showed a sharp decline to a loss of ₹2,116 Cr and negative OPM of -2.01%, contrasting with prior quarter profitability.
• Auditor change in UK subsidiaries involves KPMG LLP’s resignation due to fee disagreements, with KNAV Limited appointed; no operational or financial concerns raised.
• ⚠️ Auditor transition may introduce procedural adjustments but does not indicate material financial risk or performance deterioration.

Overall Tone: Neutral

Key Financial Highlights

What Changed

The company disclosed a change in statutory auditors for its four UK material subsidiaries, with KPMG LLP resigning effective September 16, 2026, due to disagreements over audit fee levels. KNAV Limited has been appointed as the new auditor, and the transition complies with SEBI Listing Regulations. This development is administrative and regulatory in nature, with no mention of financial restatements, regulatory penalties, or operational disruptions linked to the subsidiaries. The resignation does not reflect concerns over accounting practices or subsidiary performance. The filing underscores procedural compliance rather than strategic or financial upheaval.

Despite the auditor change, the company’s financial profile remains under pressure, with negative ROE (-9.29%) and ROCE (-3.95%) indicating challenges in generating returns on capital. The debt-to-equity ratio of 0.34 suggests moderate leverage, while a dividend yield of 1.71% may attract income-focused investors. However, the recent quarterly volatility — particularly the loss in Q4FY26 — highlights sensitivity to operational and market variables. Compared to peers like Pidilite Industries and Coromandel International, which report positive ROE and ROCE, Tata Chemicals lags in profitability metrics, though its P/B ratio of 0.77 suggests potential undervaluation relative to book value.

Peer Comparison

Tata Chemicals trades at a lower valuation multiple relative to peers but significantly underperforms on returns, with negative ROE and ROCE contrasting sharply with industry leaders.

Risks & Concerns

• No specific financial or operational risks were disclosed in the filing.
• Auditor change was attributed to fee-related disagreements, not performance or compliance issues.
• ⚠️ Persistent losses in recent quarters (e.g., ₹2,116 Cr loss in Q4FY26) pose ongoing profitability concerns.

Quarterly Trend